Physician profile

John E Mcclay

Otolaryngology · Frisco, TX

NPI 1053379370

$382.59

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$179.53

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Inspire Medical Systems, INC. $179.53 2024 Inspire
Stryker Corporation $48.94 2019-2020
Arbor Pharmaceuticals, INC. $41.37 2019-2020
Acclarent, INC $34.33 2019
Smith+Nephew, INC. $18.37 2019
Covidien Lp $17.82 2019
Novartis Pharmaceuticals Corporation $15.92 2019
Cook Medical LLC $13.31 2019
Glenmark Therapeutics INC. $13.00 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John E Mcclay

$382.59

in general payments reported 2019-2025

Years
2019-2024
Top company
Inspire Medical Systems, INC.

https://glasscript.com/doctor/2541/john-e-mcclay

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.